Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32275256!ä!32275256 Deprecated: Implicit conversion from float 203.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 203.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 203.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 203.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 203.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 203.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 203.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infez+Med 2020 ; 28 (2): 143-152 Nephropedia Template TP {{tp|p=32275256|t=2020. Vademecum for the treatment of people with COVID-19 Edition 2 0, 13 March 2020 |pdf=|usr=}}{{32275256}} gab.com Text Vademecum for the treatment of people with COVID-19 Edition 2 0, 13 March 2020 JO: Infez Med http://www.kidney.de/pget.php?&tw=1&pmid=32275256 #FOAvip The spread of COVID-19 epidemic in Italy, and particularly in Lombardy determined the need to standardize the therapeutic approach in order to offer the same indications for all hospitals in Lombardy. However, no specific drug has been previously approved for the COVID-19 treatment. The Lombardy Section of the Italian Society of Infectious and Tropical Diseases provided this <<vademecum>> with the aim to explore the current evidence about the drugs likely to be efficacious in the treatment of COVID-19. Moreover, a multidisciplinary group including critical care specialists has been created in order to provide indications about supporting measures and the use of steroids. A new grading scale has been proposed to help patients' stratification according to the severity of the respiratory conditions. Lastly, a collaborating group with immunologists and rheumatologists has been built with the aim of providing some guidance about the use of tocilizumab, a promising option for the treatment of the hyperinflammatory state occurring in most patients affected by COVID-19. Twit Text FOAVip Vademecum for the treatment of people with COVID-19 Edition 2 0, 13 March 2020 ????Infez Med http://www.kidney.de/pget.php?&tw=1&pmid=32275256 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32275256 #FOAvip English Wikipedia <ref>{{Cite pmid|32275256}}</ref> Vademecum for the treatment of people with COVID-19 Edition 2 0, 13 March 2020 #MMPMID32275256 Lombardy Section Italian Society Infectious And Tropical Diseases - Infez Med 2020[Ahe]; 28 (2): 143-152 PMID32275256show ga The spread of COVID-19 epidemic in Italy, and particularly in Lombardy determined the need to standardize the therapeutic approach in order to offer the same indications for all hospitals in Lombardy. However, no specific drug has been previously approved for the COVID-19 treatment. The Lombardy Section of the Italian Society of Infectious and Tropical Diseases provided this <> with the aim to explore the current evidence about the drugs likely to be efficacious in the treatment of COVID-19. Moreover, a multidisciplinary group including critical care specialists has been created in order to provide indications about supporting measures and the use of steroids. A new grading scale has been proposed to help patients' stratification according to the severity of the respiratory conditions. Lastly, a collaborating group with immunologists and rheumatologists has been built with the aim of providing some guidance about the use of tocilizumab, a promising option for the treatment of the hyperinflammatory state occurring in most patients affected by COVID-19. |*Pandemics[MESH] |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus/*isolation & purification[MESH] |COVID-19[MESH] |Clinical Protocols/standards[MESH] |Coronavirus Infections/*drug therapy/epidemiology/therapy[MESH] |Humans[MESH] |Italy/epidemiology[MESH] |Patient Care Team[MESH] |Patient Selection[MESH] |Pneumonia, Viral/*drug therapy/epidemiology/therapy[MESH]Vademecum for the treatment of people with COVID-19 Edition 2 0, 13 M(epmc).pdf DeepDyve Pubget Overpricing